Cabot Corporation

NYSE:CBT Rapport sur les actions

Capitalisation boursière : US$4.5b

Cabot Croissance future

Future contrôle des critères 3/6

Cabot devrait augmenter ses bénéfices et son chiffre d'affaires de 18.9% et de 3.2% par an respectivement. Le BPA devrait croître de de 20.4% par an. Le rendement des capitaux propres devrait être 21.1% dans 3 ans.

Informations clés

18.9%

Taux de croissance des bénéfices

20.45%

Taux de croissance du BPA

Chemicals croissance des bénéfices18.1%
Taux de croissance des recettes3.2%
Rendement futur des capitaux propres21.13%
Couverture par les analystes

Good

Dernière mise à jour11 Jun 2026

Mises à jour récentes de la croissance future

Recent updates

Nouveau récit Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
Seeking Alpha Mar 26

Cabot: Competitive Pressures Due To High Tire Imports Continuing To Weigh

Summary Cabot Corporation continues to face sustained volume pressure in both Reinforcement Materials and Performance Chemicals, with management candid about ongoing macro headwinds. Despite Battery Materials revenue strength, EBIT in CBT's largest segment dropped by $28 million, and cost-cutting plus reduced capex signal a defensive near-term posture. Earnings are expected to fall by approximately 14% in fiscal 2026, with further downside risk due to recent downward EPS revisions and capacity rationalization plans. Technical analysis suggests the stock is consolidating at best, with broken support levels and weakening momentum likely leading to further downside; we maintain a bearish stance. Read the full article on Seeking Alpha
Article d’analyse Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Article d’analyse Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Article d’analyse Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Article d’analyse Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Article d’analyse Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Article d’analyse Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Article d’analyse Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Article d’analyse Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Article d’analyse Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Article d’analyse Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Article d’analyse Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Article d’analyse Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Article d’analyse Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Article d’analyse Aug 19

Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)

Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...
Seeking Alpha Jul 31

Cabot Corporation: Now A 'Hold' (Rating Downgrade)

Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking Alpha
Article d’analyse Jul 18

Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43

Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...
Article d’analyse Jun 23

Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Article d’analyse Jun 09

Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw a double-digit share price...
Article d’analyse May 24

Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43

The board of Cabot Corporation ( NYSE:CBT ) has announced that it will be paying its dividend of $0.43 on the 14th of...
Seeking Alpha May 16

Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward

Summary Cabot Corporation's stock has returned approximately 38% since our 'Buy' recommendation in January. The company's Q2 earnings report showed impressive growth in both Performance Chemicals and the Reinforcement Materials business in particular. Cabot's cash flow is driving its financials, allowing for increased dividends and stock buybacks, and its forward-looking fundamentals remain bullish. Read the full article on Seeking Alpha
Article d’analyse May 13

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

The market for Cabot Corporation's ( NYSE:CBT ) stock was strong after it released a healthy earnings report last week...
Article d’analyse May 10

Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's

Cabot Corporation's ( NYSE:CBT ) dividend will be increasing from last year's payment of the same period to $0.43 on...

Prévisions de croissance des bénéfices et des revenus

NYSE:CBT - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
9/30/20283,841N/A2715615
9/30/20273,7213712685336
9/30/20263,6033082004546
3/31/20263,575281432671N/A
12/31/20253,607306401667N/A
9/30/20253,713326364665N/A
6/30/20253,815418321650N/A
3/31/20253,908426288608N/A
12/31/20243,991417420711N/A
9/30/20243,994374451692N/A
6/30/20243,958470399626N/A
3/31/20243,910443407662N/A
12/31/20233,924433385648N/A
9/30/20233,931437351595N/A
6/30/20234,078300306562N/A
3/31/20234,259315127353N/A
12/31/20224,318348-15201N/A
9/30/20224,321206-111100N/A
6/30/20224,113142-10695N/A
3/31/20223,881130-65132N/A
12/31/20213,63198-9187N/A
9/30/20213,40924762257N/A
6/30/20213,164-54103256N/A
3/31/20212,765-144184334N/A
12/31/20202,633-219132293N/A
9/30/20202,614-238177377N/A
6/30/20202,78265244475N/A
3/31/20203,109103195441N/A
12/31/20193,243127N/A507N/A
9/30/20193,337155N/A363N/A
6/30/20193,360217N/A321N/A
3/31/20193,369273N/A268N/A
12/31/20183,34377N/A214N/A
9/30/20183,242-114N/A298N/A
6/30/20183,115-136N/A300N/A
3/31/20182,966-177N/A371N/A
12/31/20172,82669N/A286N/A
9/30/20172,717246N/A348N/A
6/30/20172,613225N/A288N/A
3/31/20172,529234N/A262N/A
12/31/20162,419209N/A416N/A
9/30/20162,411145N/A392N/A
6/30/20162,463136N/A516N/A
3/31/20162,536-366N/A482N/A
12/31/20152,662-388N/A526N/A
9/30/20152,871-336N/A499N/A
6/30/20153,111-348N/A408N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CBT ( 18.9% par an) est supérieure au taux d'épargne ( 3.5% ).

Bénéfices vs marché: Les bénéfices de CBT ( 18.9% par an) devraient croître plus rapidement que le marché US ( 18.5% par an).

Croissance élevée des bénéfices: Les bénéfices de CBT devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de CBT ( 3.2% par an) devrait croître plus lentement que le marché de US ( 12.7% par an).

Croissance élevée des revenus: Le chiffre d'affaires de CBT ( 3.2% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de CBT devrait être élevé dans 3 ans ( 21.1 %)


Découvrir les entreprises en croissance

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/06/15 10:48
Cours de l'action en fin de journée2026/06/15 00:00
Les revenus2026/03/31
Revenus annuels2025/09/30

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Cabot Corporation est couverte par 11 analystes. 6 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank